{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:39:09Z","timestamp":1790386749468,"version":"4.1.0"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11850-7","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T13:15:43Z","timestamp":1777295743000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Targeting the BDNF\/TrkB\/CREB pathway: emerging strategies for neuroprotection in Parkinson\u2019s disease"],"prefix":"10.1007","volume":"53","author":[{"given":"Chetana","family":"Ahire","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginpreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"11850_CR1","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1002\/mds.27115","volume":"32","author":"JA Obeso","year":"2017","unstructured":"Obeso JA, Stamelou M, Goetz CG et al (2017) Past, present, and future of Parkinson\u2019s disease: A special essay on the 200th Anniversary of the Shaking Palsy. Movement disorders 32:1264\u20131310. https:\/\/doi.org\/10.1002\/mds.27115","journal-title":"Movement disorders"},{"key":"11850_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/neuroglia7010005","volume":"7","author":"A Dapueto","year":"2026","unstructured":"Dapueto A, Olivera-Bravo S, Prunell G (2026) Damage-Derived Reactive Glia from a Parkinson\u2019s Disease Model Are Neurotoxic to Substantia Nigra Dopaminergic Neurons in Na\u00efve Animals. Neuroglia 7:5. https:\/\/doi.org\/10.3390\/neuroglia7010005","journal-title":"Neuroglia"},{"key":"11850_CR3","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3934\/NEUROSCIENCE.2023017","volume":"10","author":"S Ramesh","year":"2023","unstructured":"Ramesh S, Arachchige ASPM (2023) Depletion of dopamine in Parkinson\u2019s disease and relevant therapeutic options: a review of the literature. AIMS Neurosci 10:200. https:\/\/doi.org\/10.3934\/NEUROSCIENCE.2023017","journal-title":"AIMS Neurosci"},{"key":"11850_CR4","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3389\/fphar.2020.00435","volume":"11","author":"E Paredes-Rodriguez","year":"2020","unstructured":"Paredes-Rodriguez E, Vegas-Suarez S, Morera-Herreras T et al (2020) The Noradrenergic System in Parkinson\u2019s Disease. Front Pharmacol 11:435. https:\/\/doi.org\/10.3389\/fphar.2020.00435","journal-title":"Front Pharmacol"},{"key":"11850_CR5","doi-asserted-by":"publisher","unstructured":"Dong-Chen X, Yong C, Yang X et al (2023) Signaling pathways in Parkinson\u2019s disease: molecular mechanisms and therapeutic interventions. Signal Transduction and Targeted Therapy 2023 8:1 8:73-. https:\/\/doi.org\/10.1038\/s41392-023-01353-3","DOI":"10.1038\/s41392-023-01353-3"},{"issue":"3 14","key":"11850_CR6","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41419-023-05672-9","volume":"14","author":"P Calabresi","year":"2023","unstructured":"Calabresi P, Mechelli A, Natale G et al (2023) Alpha-synuclein in Parkinson\u2019s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction. Cell Death Disease 2023 14(3 14):176\u2013. https:\/\/doi.org\/10.1038\/s41419-023-05672-9","journal-title":"Cell Death Disease 2023"},{"key":"11850_CR7","doi-asserted-by":"publisher","first-page":"848","DOI":"10.3390\/molecules30040848","volume":"30","author":"T Numakawa","year":"2025","unstructured":"Numakawa T, Kajihara R (2025) The Role of Brain-Derived Neurotrophic Factor as an Essential Mediator in Neuronal Functions and the Therapeutic Potential of Its Mimetics for Neuroprotection in Neurologic and Psychiatric Disorders. Molecules 30:848. https:\/\/doi.org\/10.3390\/molecules30040848","journal-title":"Molecules"},{"key":"11850_CR8","doi-asserted-by":"publisher","first-page":"252","DOI":"10.26502\/jppd.2572-519x0024","volume":"1","author":"M Angoa-P\u00e9rez","year":"2017","unstructured":"Angoa-P\u00e9rez M, Anneken JH, Kuhn DM (2017) The Role of Brain-Derived Neurotrophic Factor in the Pathophysiology of Psychiatric and Neurological Disorders. J Psychiatry Psychiatr Disord 1:252. https:\/\/doi.org\/10.26502\/jppd.2572-519x0024","journal-title":"J Psychiatry Psychiatr Disord"},{"key":"11850_CR9","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.3390\/ijms21031170","volume":"21","author":"E Palasz","year":"2020","unstructured":"Palasz E, Wysocka A, Gasiorowska A et al (2020) BDNF as a Promising Therapeutic Agent in Parkinson\u2019s Disease. Int J Mol Sci 21:1170. https:\/\/doi.org\/10.3390\/ijms21031170","journal-title":"Int J Mol Sci"},{"key":"11850_CR10","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.3390\/ijms21031170","volume":"21","author":"E Palasz","year":"2020","unstructured":"Palasz E, Wysocka A, Gasiorowska A et al (2020) BDNF as a Promising Therapeutic Agent in Parkinson\u2019s Disease. Int J Mol Sci 2020 21:1170 Page 1170 21:. https:\/\/doi.org\/10.3390\/ijms21031170","journal-title":"Int J Mol Sci 2020"},{"key":"11850_CR11","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.5114\/aoms.2015.56342","volume":"11","author":"S Bathina","year":"2015","unstructured":"Bathina S, Das UN (2015) Brain-derived neurotrophic factor and its clinical implications. Arch Med Sci 11:1164. https:\/\/doi.org\/10.5114\/aoms.2015.56342","journal-title":"Arch Med Sci"},{"key":"11850_CR12","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/jnr.21139","volume":"85","author":"T Aid","year":"2007","unstructured":"Aid T, Kazantseva A, Piirsoo M et al (2007) Mouse and rat BDNF gene structure and expression revisited. J Neurosci Res 85:525\u2013535. https:\/\/doi.org\/10.1002\/jnr.21139","journal-title":"J Neurosci Res"},{"key":"11850_CR13","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s10571-017-0510-4","volume":"38","author":"P Kowia\u0144ski","year":"2018","unstructured":"Kowia\u0144ski P, Lietzau G, Czuba E et al (2018) BDNF: A Key Factor with Multipotent Impact on Brain Signaling and Synaptic Plasticity. Cell Mol Neurobiol 38:579\u2013593. https:\/\/doi.org\/10.1007\/s10571-017-0510-4","journal-title":"Cell Mol Neurobiol"},{"key":"11850_CR14","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3233\/JAD-215193","volume":"85","author":"D Cutuli","year":"2022","unstructured":"Cutuli D, Landolfo E, Petrosini L, Gelfo F (2022) Environmental Enrichment Effects on the Brain-Derived Neurotrophic Factor Expression in Healthy Condition, Alzheimer\u2019s Disease, and Other Neurodegenerative Disorders. J Alzheimer\u2019s Disease 85:975\u2013992. https:\/\/doi.org\/10.3233\/JAD-215193","journal-title":"J Alzheimer\u2019s Disease"},{"key":"11850_CR15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nn.2244","volume":"12","author":"J Yang","year":"2009","unstructured":"Yang J, Siao CJ, Nagappan G et al (2009) Neuronal release of proBDNF. Nat Neurosci 12:113\u2013115. https:\/\/doi.org\/10.1038\/nn.2244","journal-title":"Nat Neurosci"},{"key":"11850_CR16","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/mp.2017.61","volume":"22","author":"E Castr\u00e9n","year":"2017","unstructured":"Castr\u00e9n E, Antila H (2017) Neuronal plasticity and neurotrophic factors in drug responses. Mol Psychiatry 22:1085\u20131095. https:\/\/doi.org\/10.1038\/mp.2017.61","journal-title":"Mol Psychiatry"},{"key":"11850_CR17","doi-asserted-by":"publisher","first-page":"7777","DOI":"10.3390\/ijms21207777","volume":"21","author":"L Colucci-D\u2019amato","year":"2020","unstructured":"Colucci-D\u2019amato L, Speranza L, Volpicelli F (2020) Neurotrophic Factor BDNF, Physiological Functions and Therapeutic Potential in Depression, Neurodegeneration and Brain Cancer. Int J Mol Sci 21:7777. https:\/\/doi.org\/10.3390\/ijms21207777","journal-title":"Int J Mol Sci"},{"key":"11850_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2018.00156","author":"SJ Tsai","year":"2018","unstructured":"Tsai SJ (2018) Critical Issues in BDNF Val66Met Genetic Studies of Neuropsychiatric Disorders. Front Mol Neurosci. https:\/\/doi.org\/10.3389\/fnmol.2018.00156","journal-title":"Front Mol Neurosci"},{"key":"11850_CR19","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.expneurol.2010.12.018","volume":"228","author":"M Baydyuk","year":"2010","unstructured":"Baydyuk M, Nguyen MT, Xu B (2010) Chronic Deprivation of TrkB Signaling Leads to Selective Late-onset Nigrostriatal Dopaminergic Degeneration. Exp Neurol 228:118. https:\/\/doi.org\/10.1016\/j.expneurol.2010.12.018","journal-title":"Exp Neurol"},{"key":"11850_CR20","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/cjp2.307","volume":"9","author":"Y Li","year":"2022","unstructured":"Li Y, Wei C, Wang W et al (2022) Tropomyosin receptor kinase B (TrkB) signalling: targeted therapy in neurogenic tumours. J Pathol Clin Res 9:89. https:\/\/doi.org\/10.1002\/cjp2.307","journal-title":"J Pathol Clin Res"},{"key":"11850_CR21","doi-asserted-by":"publisher","first-page":"122282","DOI":"10.1016\/j.lfs.2023.122282","volume":"336","author":"Y Wang","year":"2024","unstructured":"Wang Y, Liang J, Xu B et al (2024) TrkB\/BDNF signaling pathway and its small molecular agonists in CNS injury. Life Sci 336:122282. https:\/\/doi.org\/10.1016\/j.lfs.2023.122282","journal-title":"Life Sci"},{"key":"11850_CR22","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1146\/annurev.biochem.72.121801.161629","volume":"72","author":"EJ Huang","year":"2003","unstructured":"Huang EJ, Reichardt LF (2003) Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem 72:609\u2013642. https:\/\/doi.org\/10.1146\/annurev.biochem.72.121801.161629","journal-title":"Annu Rev Biochem"},{"key":"11850_CR23","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/S0959-4388(00)00208-7","volume":"11","author":"A Patapoutian","year":"2001","unstructured":"Patapoutian A, Reichardt LF (2001) Trk receptors: Mediators of neurotrophin action. Curr Opin Neurobiol 11:272\u2013280. https:\/\/doi.org\/10.1016\/S0959-4388(00)00208-7","journal-title":"Curr Opin Neurobiol"},{"key":"11850_CR24","doi-asserted-by":"publisher","first-page":"27571","DOI":"10.1074\/jbc.M114.562561","volume":"289","author":"X Liu","year":"2014","unstructured":"Liu X, Obiany O, Chan CB et al (2014) Biochemical and Biophysical Investigation of the Brain-derived Neurotrophic Factor Mimetic 7,8-Dihydroxyflavone in the Binding and Activation of the TrkB Receptor. J Biol Chem 289:27571. https:\/\/doi.org\/10.1074\/jbc.M114.562561","journal-title":"J Biol Chem"},{"key":"11850_CR25","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0959-4388(00)00211-7","volume":"11","author":"A Brunet","year":"2001","unstructured":"Brunet A, Datta SR, Greenberg ME (2001) Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr Opin Neurobiol 11:297\u2013305. https:\/\/doi.org\/10.1016\/S0959-4388(00)00211-7","journal-title":"Curr Opin Neurobiol"},{"key":"11850_CR26","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1007\/s12264-017-0168-4","volume":"33","author":"R Wang","year":"2017","unstructured":"Wang R, Yang S, Nie T et al (2017) Transcription Factors: Potential Cell Death Markers in Parkinson\u2019s Disease. Neurosci Bull 33:552\u2013560. https:\/\/doi.org\/10.1007\/s12264-017-0168-4","journal-title":"Neurosci Bull"},{"key":"11850_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9010257","author":"W Jin","year":"2020","unstructured":"Jin W (2020) Regulation of BDNF-TrkB Signaling and Potential Therapeutic Strategies for Parkinson\u2019s Disease. J Clin Med. https:\/\/doi.org\/10.3390\/jcm9010257","journal-title":"J Clin Med"},{"key":"11850_CR28","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1096\/fj.05-3845fje","volume":"19","author":"O von Bohlen","year":"2005","unstructured":"von Bohlen O, Minichiello L, Unsicker K (2005) Haploinsufficiency for trkB and trkC receptors induces cell loss and accumulation of alpha-synuclein in the substantia nigra. FASEB J 19:1740\u20131742. https:\/\/doi.org\/10.1096\/fj.05-3845fje","journal-title":"FASEB J"},{"key":"11850_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1471-4159.2010.07080.x","volume":"116","author":"K Sakamoto","year":"2010","unstructured":"Sakamoto K, Karelina K, Obrietan K (2010) CREB: a multifaceted regulator of neuronal plasticity and protection. J Neurochem 116:1. https:\/\/doi.org\/10.1111\/j.1471-4159.2010.07080.x","journal-title":"J Neurochem"},{"key":"11850_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11010-022-04472-7","volume":"477","author":"RK Narasimhamurthy","year":"2022","unstructured":"Narasimhamurthy RK, Andrade D, Mumbrekar KD (2022) Modulation of CREB and its associated upstream signaling pathways in pesticide-induced neurotoxicity. Mol Cell Biochem 2022 477:11. https:\/\/doi.org\/10.1007\/s11010-022-04472-7","journal-title":"Mol Cell Biochem 2022"},{"key":"11850_CR31","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S0092-8674(00)80595-4","volume":"96","author":"A Brunet","year":"1999","unstructured":"Brunet A, Bonni A, Zigmond MJ et al (1999) Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell 96:857\u2013868. https:\/\/doi.org\/10.1016\/S0092-8674(00)80595-4","journal-title":"Cell"},{"key":"11850_CR32","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.tins.2004.08.001","volume":"27","author":"MP Mattson","year":"2004","unstructured":"Mattson MP, Maudsley S, Martin B (2004) BDNF and 5-HT: A dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends Neurosci 27:589\u2013594. https:\/\/doi.org\/10.1016\/j.tins.2004.08.001","journal-title":"Trends Neurosci"},{"key":"11850_CR33","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12929-024-01037-2","volume":"31","author":"HW Lee","year":"2024","unstructured":"Lee HW, Chen SJ, Tsai KJ, Chen SJ, Tsai KJ, Hsu KS, Chen YF, Chang CH, Lin HH, Hsueh WY et al (2024) HP HsiehJournal of biomedical science, 2024\u2022Springer 31:46. https:\/\/doi.org\/10.1186\/s12929-024-01037-2","journal-title":"2024\u2022Springer"},{"key":"11850_CR34","doi-asserted-by":"publisher","first-page":"8042","DOI":"10.1523\/JNEUROSCI.2063-19.2020","volume":"40","author":"A Gonz\u00e1lez-Guti\u00e9rrez","year":"2020","unstructured":"Gonz\u00e1lez-Guti\u00e9rrez A, Lazo OM, Bronfman FC (2020) The Rab5-Rab11 Endosomal Pathway is Required for BDNF-Induced CREB Transcriptional Regulation in Hippocampal Neurons. J Neurosci 40:8042\u20138054. https:\/\/doi.org\/10.1523\/JNEUROSCI.2063-19.2020","journal-title":"J Neurosci"},{"key":"11850_CR35","unstructured":"Esvald E, Tuvikene J, Sirp A, Tuvikene J, Sirp A, Patil S, Bramham CR et al T TimmuskJournal of Neuroscience, 2020\u2022jneurosci.org"},{"key":"11850_CR36","unstructured":"Huang Y, Huang C, Neuroscience WY-J, of C, Huang C W YunJournal of Clinical Neuroscience, 2019\u2022Elsevier"},{"key":"11850_CR37","doi-asserted-by":"crossref","unstructured":"Elkouzi A, Vedam-Mai V, \u2026 RE-NR, 2019 undefined Emerging therapies in Parkinson disease\u2014repurposed drugs and new approaches. nature.comA Elkouzi, V Vedam-Mai, RS Eisinger, MS OkunNature Reviews Neurology, 2019\u2022nature.com","DOI":"10.1038\/s41582-019-0155-7"},{"key":"11850_CR38","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1056\/NEJM199810153391607","volume":"339","author":"P Arkinson","year":"1998","unstructured":"Arkinson P, Isease SD, Nthony L, Ang AE, Ndres L, Ozano AM (1998) Parkinson\u2019s disease. Mass Medical SocAE Lang, AM LozanoNew England Journal of Medicine. 1998\u2022Mass Med Soc 339:1130\u20131143. https:\/\/doi.org\/10.1056\/NEJM199810153391607","journal-title":"1998\u2022Mass Med Soc"},{"key":"11850_CR39","unstructured":"Mogi M, Togari A, Kondo T, Togari A, Kondo T, Mizuno Y, Komure O, Kuno S, Ichinose H et al T NagatsuNeuroscience letters, 1999\u2022Elsevier"},{"key":"11850_CR40","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1038\/s41598-023-29287-4","volume":"13","author":"R Singh","year":"2023","unstructured":"Singh R, Zahra W, Singh S, Sen et al (2023) Oleuropein confers neuroprotection against rotenone-induced model of Parkinson\u2019s disease via BDNF\/CREB\/Akt pathway. Sci Rep 13:2452. https:\/\/doi.org\/10.1038\/s41598-023-29287-4","journal-title":"Sci Rep"},{"key":"11850_CR41","doi-asserted-by":"publisher","first-page":"10773","DOI":"10.1073\/pnas.1713969114","volume":"114","author":"SS Kang","year":"2017","unstructured":"Kang SS, Zhang Z, Liu X et al (2017) TrkB neurotrophic activities are blocked by \u03b1-synuclein, triggering dopaminergic cell death in Parkinson\u2019s disease. Proc Natl Acad Sci U S A 114:10773\u201310778. https:\/\/doi.org\/10.1073\/pnas.1713969114","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11850_CR42","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nrneurol.2009.54","volume":"5","author":"C Zuccato","year":"2009","unstructured":"Zuccato C, Cattaneo E (2009) Brain-derived neurotrophic factor in neurodegenerative diseases. Nat Rev Neurol 5:311\u2013322. https:\/\/doi.org\/10.1038\/nrneurol.2009.54","journal-title":"Nat Rev Neurol"},{"key":"11850_CR43","doi-asserted-by":"publisher","unstructured":"Sawada M, Imamura K, Nagatsu T (2006) Role of cytokines in inflammatory process in Parkinson\u2019s disease. J Neural Transm Suppl 373\u2013381. https:\/\/doi.org\/10.1007\/978-3-211-45295-0_57","DOI":"10.1007\/978-3-211-45295-0_57"},{"key":"11850_CR44","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1006\/exnr.2000.7483","volume":"166","author":"DW Howells","year":"2000","unstructured":"Howells DW, Porritt MJ, Wong JYF et al (2000) Reduced BDNF mRNA expression in the Parkinson\u2019s disease substantia nigra. Exp Neurol 166:127\u2013135. https:\/\/doi.org\/10.1006\/exnr.2000.7483","journal-title":"Exp Neurol"},{"key":"11850_CR45","doi-asserted-by":"publisher","unstructured":"Numakawa T, Odaka H, Adachi N (2018) Actions of Brain-Derived Neurotrophin Factor in the Neurogenesis and Neuronal Function, and Its Involvement in the Pathophysiology of Brain Diseases. Int J Mol Sci 19. https:\/\/doi.org\/10.3390\/ijms19113650","DOI":"10.3390\/ijms19113650"},{"key":"11850_CR46","doi-asserted-by":"publisher","first-page":"106238","DOI":"10.1016\/j.nbd.2023.106238","volume":"185","author":"A Pelosi","year":"2023","unstructured":"Pelosi A, Nakamura Y, Girault JA, Herv\u00e9 D (2023) BDNF\/TrkB pathway activation in D1 receptor-expressing striatal projection neurons plays a protective role against L-DOPA-induced dyskinesia. Neurobiol Dis 185:106238. https:\/\/doi.org\/10.1016\/j.nbd.2023.106238","journal-title":"Neurobiol Dis"},{"key":"11850_CR47","doi-asserted-by":"publisher","unstructured":"Palasz E, Wysocka A, Gasiorowska A et al (2020) BDNF as a Promising Therapeutic Agent in Parkinson\u2019s Disease. Int J Mol Sci 21. https:\/\/doi.org\/10.3390\/ijms21031170","DOI":"10.3390\/ijms21031170"},{"key":"11850_CR48","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.3233\/JPD-202061","volume":"10","author":"S Scheggi","year":"2020","unstructured":"Scheggi S, Rossi F, Corsi S et al (2020) BDNF Overexpression Increases Striatal D3 Receptor Level at Striatal Neurons and Exacerbates D1-Receptor Agonist-Induced Dyskinesia. J Parkinsons Dis 10:1503\u20131514. https:\/\/doi.org\/10.3233\/JPD-202061","journal-title":"J Parkinsons Dis"},{"key":"11850_CR49","doi-asserted-by":"publisher","first-page":"9930","DOI":"10.1523\/jneurosci.21-24-09930.2001","volume":"21","author":"M Andersson","year":"2001","unstructured":"Andersson M, Konradi C, Angela Cenci M (2001) cAMP response element-binding protein is required for dopamine-dependent gene expression in the intact but not the dopamine-denervated striatum. J Neurosci 21:9930\u20139943. https:\/\/doi.org\/10.1523\/jneurosci.21-24-09930.2001","journal-title":"J Neurosci"},{"key":"11850_CR50","unstructured":"Xu X, He X, Zhang Z, He X, Zhang Z, Chen Y, Li J, Ma S, Huang Q et al M LiJournal of Neuroscience, 2022\u2022jneurosci.org"},{"key":"11850_CR51","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s10787-023-01305-x","volume":"32","author":"HA Farid","year":"2023","unstructured":"Farid HA, Sayed RH, El-Shamarka MES et al (2023) PI3K\/AKT signaling activation by roflumilast ameliorates rotenone-induced Parkinson\u2019s disease in rats. Inflammopharmacology 2023 32:2. https:\/\/doi.org\/10.1007\/s10787-023-01305-x","journal-title":"Inflammopharmacology 2023"},{"key":"11850_CR52","doi-asserted-by":"publisher","unstructured":"Chalimoniuk M, Snoek GT, Adamczyk A Phosphatidylinositol transfer protein expression altered by aging and Parkinson disease. SpringerM Chalimoniuk, Snoek GT, Adamczyk A et al (2006) A Ma\u0142ecki, JB StrosznajderCellular and molecular neurobiology, 2006\u2022Springer 26:1153\u20131166. https:\/\/doi.org\/10.1007\/s10571-006-9078-0","DOI":"10.1007\/s10571-006-9078-0"},{"key":"11850_CR53","doi-asserted-by":"publisher","unstructured":"Bogetofte H, Alamyar A, \u2026 MB-C& N, 2020 undefined (2020) Levodopa therapy for Parkinson\u2019s disease: history, current status and perspectives. benthamdirect.comH Bogetofte, A Alamyar, M Blaabjerg, M MeyerCNS & Neurological Disorders-Drug Targets-CNS & Neurological Disorders), 2020\u2022benthamdirect.com 19:572\u2013583. https:\/\/doi.org\/10.2174\/1871527319666200722153156","DOI":"10.2174\/1871527319666200722153156"},{"key":"11850_CR54","doi-asserted-by":"publisher","unstructured":"Leino S, Kohtala S, Rantam\u00e4ki T, Kohtala S, Rantam\u00e4ki T, Koski SK, Rannanp\u00e4\u00e4 S et al (2018) O SalminenBMC neuroscience, 2018\u2022Springer 19:. https:\/\/doi.org\/10.1186\/s12868-018-0478-0","DOI":"10.1186\/s12868-018-0478-0"},{"key":"11850_CR55","unstructured":"Zhang X, Andren P, research PS-B, Andren PE (2006) P SvenningssonBrain research, 2006\u2022Elsevier"},{"key":"11850_CR56","unstructured":"Okazawa H, Murata M, Watanabe M, Murata M, Watanabe M, Kamei M et al I KanazawaFEBS letters, 1992\u2022Elsevier"},{"key":"11850_CR57","unstructured":"Guillin O, Diaz J, Carroll P, Diaz J, Carroll P, Griffon N, Schwartz JC et al P SokoloffNature, 2001\u2022nature.com"},{"key":"11850_CR58","doi-asserted-by":"crossref","unstructured":"Guillin O, Demily C neurobiology FT-I review of, 2007 undefined Brain-derived neurotrophic factor in schizophrenia and its relation with dopamine. Elsevier","DOI":"10.1016\/S0074-7742(06)78012-6"},{"key":"11850_CR59","unstructured":"Narita M, Aoki K, Takagi M, Aoki K, Takagi M, Yajima Y et al T SuzukiNeuroscience, 2003\u2022Elsevier"},{"key":"11850_CR60","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1038\/sj.npp.1301615","volume":"33","author":"F Meisner","year":"2008","unstructured":"Meisner F, Scheller C, Kneitz S, Scheller C, Kneitz S, Sopper S, Neuen-Jacob E, Riederer P, MeulenNeuropsychopharmacology V et al (2008) 2008\u2022nature com 33:2228\u20132236. https:\/\/doi.org\/10.1038\/sj.npp.1301615","journal-title":"2008\u2022nature com"},{"key":"11850_CR61","doi-asserted-by":"publisher","unstructured":"Pochwat B, Nowak G, Szewczyk B An update on NMDA antagonists in depression. TaylorFrancisB Pochwat, Nowak G (2019) B SzewczykExpert review of neurotherapeutics, 2019\u2022Taylor & Francis 19:1055\u20131067. https:\/\/doi.org\/10.1080\/14737175.2019.1643237","DOI":"10.1080\/14737175.2019.1643237"},{"key":"11850_CR62","unstructured":"Zhu W, Fan Y, Li Y, Fan Y, Li Y, Peng L, Li Y, Yan F, Zhao J, Zhang L, Kurihara H, He R et al H ChenBioorganic Chemistry, 2023\u2022Elsevier"},{"key":"11850_CR63","unstructured":"Research MK-P 2020 undefined Galantamine-Memantine combination in the treatment of Alzheimer\u2019s disease and beyond. ElsevierMM KoolaPsychiatry Research, 2020\u2022Elsevier"},{"key":"11850_CR64","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1017\/S1461145705005663","volume":"9","author":"M Kubera","year":"2006","unstructured":"Kubera M, Basta-Kaim A, Budziszewska B et al (2006) Effect of amantadine and imipramine on immunological parameters of rats subjected to a forced swimming test. Int J Neuropsychopharmacol 9:297\u2013305. https:\/\/doi.org\/10.1017\/S1461145705005663","journal-title":"Int J Neuropsychopharmacol"},{"key":"11850_CR65","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.pharep.2017.02.022","volume":"69","author":"Z Rog\u00f3\u017c","year":"2017","unstructured":"Rog\u00f3\u017c Z, Kami\u0144ska K, Pa\u0144czyszyn-Trzewik P, Sowa-Ku\u0107ma M (2017) Repeated co-treatment with antidepressants and risperidone increases BDNF mRNA and protein levels in rats. Pharmacol Rep 69:885\u2013893. https:\/\/doi.org\/10.1016\/j.pharep.2017.02.022","journal-title":"Pharmacol Rep"},{"key":"11850_CR66","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1590\/1516-4446-2017-2393","volume":"40","author":"IF Raupp-Barcaro","year":"2018","unstructured":"Raupp-Barcaro IF, Vital MA, Galdur\u00f3z JC, Andreatini R (2018) Potential antidepressant effect of amantadine: a review of preclinical studies and clinical trials. Braz J Psychiatry 40:449. https:\/\/doi.org\/10.1590\/1516-4446-2017-2393","journal-title":"Braz J Psychiatry"},{"key":"11850_CR67","doi-asserted-by":"publisher","unstructured":"Zhong J, Li J, Ni C, Zuo Z (2020) Amantadine alleviates postoperative cognitive dysfunction possibly by preserving neurotrophic factor expression and dendritic arborization in the. frontiersin.orgJ Zhong, J Li, C Ni, Z ZuoFrontiers in Aging Neuroscience, 2020\u2022frontiersin.org 12:. https:\/\/doi.org\/10.3389\/fnagi.2020.605330","DOI":"10.3389\/fnagi.2020.605330"},{"key":"11850_CR68","unstructured":"Rogoz Z, Skuza G, of physiology BL-J, undefined Repeated co-treatment with imipramine and amantadine induces hippocampal brain-derived neurotrophic factor gene expression in rats. researchgate.netZ Rogoz, Skuza G (2007) B LegutkoJournal of physiology and pharmacology, 2007\u2022researchgate.net"},{"key":"11850_CR69","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1080\/02699052.2020.1723697","volume":"34","author":"HM Ma","year":"2020","unstructured":"Ma HM, Zafonte RD (2020) Amantadine and memantine: a comprehensive review for acquired brain injury. Brain Inj 34:299\u2013315. https:\/\/doi.org\/10.1080\/02699052.2020.1723697","journal-title":"Brain Inj"},{"key":"11850_CR70","doi-asserted-by":"crossref","unstructured":"\u015awietlik D, Kusiak A, Environmental AO-IJ, of 2022 undefined Computational modeling of therapy with the NMDA antagonist in neurodegenerative disease: information theory in the mechanism of action of memantine. mdpi.comD \u015awietlik, A Kusiak, A OssowskaInternational Journal of Environmental Research and Public Health, 2022\u2022mdpi.com","DOI":"10.3390\/ijerph19084727"},{"key":"11850_CR71","doi-asserted-by":"publisher","unstructured":"Yick LW, Tang CH, Ma OKF Memantine ameliorates motor impairments and pathologies in a mouse model of neuromyelitis optica spectrum disorders. SpringerLW Yick, Tang CH, Ma OKF, Kwan JSC et al (2020) KH ChanJournal of Neuroinflammation, 2020\u2022Springer 17:. https:\/\/doi.org\/10.1186\/s12974-020-01913-2","DOI":"10.1186\/s12974-020-01913-2"},{"key":"11850_CR72","unstructured":"Ng T, Ho C, Tam W, Ho CSH, Tam WWS, Kua EH et al RCM HoInternational journal of molecular sciences, 2019\u2022mdpi.com"},{"key":"11850_CR73","doi-asserted-by":"publisher","unstructured":"Carradori S, D\u2019Ascenzio M, Chimenti P Selective MAO-B inhibitors: a lesson from natural products. SpringerS, Carradori M, D\u2019Ascenzio P, Chimenti D, Secci et al (2014) A BolascoMolecular diversity, 2014\u2022Springer 18:219\u2013243. https:\/\/doi.org\/10.1007\/s11030-013-9490-6","DOI":"10.1007\/s11030-013-9490-6"},{"key":"11850_CR74","doi-asserted-by":"publisher","unstructured":"Moore JJ, Saadabadi A (2023) Selegiline. xPharm: The Comprehensive Pharmacology Reference 1\u20134. https:\/\/doi.org\/10.1016\/B978-008055232-3.62607-8","DOI":"10.1016\/B978-008055232-3.62607-8"},{"key":"11850_CR75","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/jnr.10148","volume":"67","author":"M Ebadi","year":"2002","unstructured":"Ebadi M, Sharma S, Shavali S, El Refaey H (2002) Neuroprotective actions of selegiline. J Neurosci Res 67:285\u2013289. https:\/\/doi.org\/10.1002\/jnr.10148","journal-title":"J Neurosci Res"},{"key":"11850_CR76","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26031248","volume":"26","author":"O Buneeva","year":"2025","unstructured":"Buneeva O, Medvedev A (2025) Monoamine Oxidase Inhibitors in Toxic Models of Parkinsonism. Int J Mol Sci 26:1248. https:\/\/doi.org\/10.3390\/ijms26031248","journal-title":"Int J Mol Sci"},{"key":"11850_CR77","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.clinthera.2007.09.021","volume":"29","author":"JJ Chen","year":"2007","unstructured":"Chen JJ, Swope DM, Dashtipour K (2007) Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson\u2019s Disease. Clin Ther 29:1825\u20131849. https:\/\/doi.org\/10.1016\/j.clinthera.2007.09.021","journal-title":"Clin Ther"},{"key":"11850_CR78","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.nbd.2006.07.020","volume":"25","author":"Y Sagi","year":"2007","unstructured":"Sagi Y, Mandel S, Amit T, Youdim MBH (2007) Activation of tyrosine kinase receptor signaling pathway by rasagiline facilitates neurorescue and restoration of nigrostriatal dopamine neurons in post-MPTP-induced parkinsonism. Neurobiol Dis 25:35\u201344. https:\/\/doi.org\/10.1016\/j.nbd.2006.07.020","journal-title":"Neurobiol Dis"},{"key":"11850_CR79","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.2147\/TCRM.S139545","volume":"14","author":"S Bette","year":"2018","unstructured":"Bette S, Shpiner DS, Singer C, Moore H (2018) Safinamide in the management of patients with Parkinson\u2019s disease not stabilized on levodopa: a review of the current clinical evidence. Ther Clin Risk Manag 14:1737. https:\/\/doi.org\/10.2147\/TCRM.S139545","journal-title":"Ther Clin Risk Manag"},{"key":"11850_CR80","unstructured":"Yeo Y, Yap Y, Ng K, Yap YJ, Ng KY, Chye SM, Ling APK, Ooi YY, Tiong YL et al RY KohJournal of Applied Pharmaceutical Science, 2024\u2022japsonline.com"},{"key":"11850_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2020.110094","author":"A Sepehr","year":"2020","unstructured":"Sepehr A, Taheri F, Heidarian S et al (2020) Neuroprotective and neuro-survival properties of safinamide against methamphetamine-induced neurodegeneration: hypothetic possible role of BDNF\/TrkB\/PGC-1\u03b1 signaling pathway and mitochondrial uncoupling protein\u2009\u2212\u20092(UCP-2). Med Hypotheses. https:\/\/doi.org\/10.1016\/j.mehy.2020.110094","journal-title":"Med Hypotheses"},{"key":"11850_CR82","doi-asserted-by":"publisher","unstructured":"Weinstock M, Luques L, Bejar C, Shoham S (2006) Ladostigil, a novel multifunctional drug for the treatment of dementia co-morbid with depression. J Neural Transm Suppl 443\u2013446. https:\/\/doi.org\/10.1007\/978-3-211-45295-0_67","DOI":"10.1007\/978-3-211-45295-0_67"},{"key":"11850_CR83","unstructured":"neurobiology MY-E (2013) undefined Multi target neuroprotective and neurorestorative anti-Parkinson and anti-Alzheimer drugs ladostigil and m30 derived from rasagiline. YoudimExperimental neurobiology. pmc.ncbi.nlm.nih.govMBH 2013\u2022pmc.ncbi.nlm.nih.gov"},{"key":"11850_CR84","doi-asserted-by":"publisher","unstructured":"LeWitt PA (2010) Dopaminergic Agonists in Parkinson\u2019s Disease. Encyclopedia Mov Disorders Three\u2013Volume Set V1\u2013332\u2013V1\u2013337. https:\/\/doi.org\/10.1016\/B978-0-12-374105-9.00234-3","DOI":"10.1016\/B978-0-12-374105-9.00234-3"},{"key":"11850_CR85","unstructured":"Ohta K, Kuno S, Mizuta I, Kuno S, Mizuta I, Fujinami A, Matsui H et al M OhtaLife sciences, 2003\u2022Elsevier"},{"key":"11850_CR86","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/S0024-3205(03)00321-7","volume":"73","author":"K Ohta","year":"2003","unstructured":"Ohta K, Kuno S, Mizuta I et al (2003) Effects of dopamine agonists bromocriptine, pergolide, cabergoline, and SKF-38393 on GDNF, NGF, and BDNF synthesis in cultured mouse astrocytes. Life Sci 73:617\u2013626. https:\/\/doi.org\/10.1016\/S0024-3205(03)00321-7","journal-title":"Life Sci"},{"key":"11850_CR87","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.neulet.2017.10.006","volume":"662","author":"N Adachi","year":"2018","unstructured":"Adachi N, Yoshimura A, Chiba S et al (2018) Rotigotine, a dopamine receptor agonist, increased BDNF protein levels in the rat cortex and hippocampus. Neurosci Lett 662:44\u201350. https:\/\/doi.org\/10.1016\/j.neulet.2017.10.006","journal-title":"Neurosci Lett"},{"key":"11850_CR88","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/jnr.20387","volume":"79","author":"M Penkowa","year":"2005","unstructured":"Penkowa M, Florit S, Giralt M, Florit S, Giralt M, Quintana A, Molinero A, Carrasco J et al (2005) J HidalgoJournal Neurosci Res 2005\u2022Wiley Online Libr 79:522\u2013534. https:\/\/doi.org\/10.1002\/jnr.20387","journal-title":"J HidalgoJournal Neurosci Res 2005\u2022Wiley Online Libr"},{"key":"11850_CR89","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00441-020-03224-7","volume":"382","author":"T Andreska","year":"2020","unstructured":"Andreska T, L\u00fcningschr\u00f6r P, Sendtner M (2020) Regulation of TrkB cell surface expression\u2014a mechanism for modulation of neuronal responsiveness to brain-derived neurotrophic factor. Cell Tissue Res 382:5. https:\/\/doi.org\/10.1007\/s00441-020-03224-7","journal-title":"Cell Tissue Res"},{"key":"11850_CR90","doi-asserted-by":"crossref","unstructured":"Jiang M, Peng Q, Liu X et al Small-molecule TrkB receptor agonists improve motor function and extend survival in a mouse model of Huntington\u2019s disease. academic.oup.comM Jiang, Q Peng, X Liu, J Jin, Z Hou, J Zhang, S Mori, CA Ross, K Ye, W DuanHuman molecular genetics, 2013\u2022academic.oup.com","DOI":"10.1093\/hmg\/ddt098"},{"key":"11850_CR91","unstructured":"Pharmacology AB-B (2022) undefined Cholinergic models of memory impairment in animals and man: scopolamine vs. biperiden. journals.lww.comA BloklandBehavioural Pharmacology, 2022\u2022journals.lww.com"},{"key":"11850_CR92","unstructured":"Zhou D, Zhang Z, Liu L et al The antidepressant-like effects of biperiden may involve BDNF\/TrkB signaling-mediated BICC1 expression in the hippocampus and prefrontal cortex of mice. Elsevier"},{"key":"11850_CR93","doi-asserted-by":"crossref","unstructured":"Richter M, Donath F, \u2026 RW-\u2026 J of C, 2021 undefined Pharmacokinetics of oral pridinol:results of a randomized, crossover bioequivalence trial in healthy subjects. pmc.ncbi.nlm.nih.govM Richter, F Donath, RS Wedemeyer, A Warnke, A Horstmann, C PeschelInternational Journal of Clinical Pharmacology and Therapeutics, 2021\u2022pmc.ncbi.nlm.nih.gov","DOI":"10.5414\/CP203900"},{"key":"11850_CR94","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1080\/14656566.2022.2060738","volume":"23","author":"A Salamon","year":"2022","unstructured":"Salamon A, Z\u00e1dori D, Szpisjak L, Z\u00e1dori D, Szpisjak L, Kliv\u00e9nyi P et al (2022) L V\u00e9cseiExpert Opin Pharmacotherapy 2022\u2022Taylor Francis 23:1123\u20131128. https:\/\/doi.org\/10.1080\/14656566.2022.2060738","journal-title":"L V\u00e9cseiExpert Opin Pharmacotherapy 2022\u2022Taylor Francis"},{"key":"11850_CR95","unstructured":"Yoo D, Jung H, Kim W, et al Entacapone promotes hippocampal neurogenesis in mice.journals.lww.comDY Yoo, HY Jung, W Kim, KR Hahn, HJ Kwon, SM Nam, JY Chung, YS Yoon,DW KimNeural Regeneration Research, 2021\u2022journals.lww.com"},{"key":"11850_CR96","unstructured":"Giakoumaki S, \u2026 PR-TIJ, 2008 undefined Tolcapone enhances prepulse inhibition (PPI)of the startle reflex and working memory function in a COMT Val158Met genotype-specific manner. search.proquest.comS Giakoumaki, P Roussos, P BitsiosThe International Journal of Neuropsychopharmacology, 2008\u2022search.proquest.com"},{"key":"11850_CR97","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/npp.2013.243","volume":"39","author":"Z Zhang","year":"2014","unstructured":"Zhang Z, Liu X, Schroeder JP, Liu X, Schroeder JP, Chan CB, Song M, Yu SP, Weinshenker D, YeNeuropsychopharmacology K et al (2014) 2014\u2022nature com 39:638\u2013650. https:\/\/doi.org\/10.1038\/npp.2013.243","journal-title":"2014\u2022nature com"},{"key":"11850_CR98","doi-asserted-by":"publisher","unstructured":"Liu X, Chan CB, Jang SW A synthetic 7, 8-dihydroxyflavone derivative promotes neurogenesis and exhibits potent antidepressant effect. ACS PublicationsX Liu, Chan CB, Jang SW, Pradoldej S, Huang J, He K, Phun LH, France S, Xiao G et al (2010) Y JiaJournal of medicinal chemistry, 2010\u2022ACS Publications 53:8274\u20138286. https:\/\/doi.org\/10.1021\/jm101206p","DOI":"10.1021\/jm101206p"},{"key":"11850_CR99","doi-asserted-by":"publisher","unstructured":"Li XH, Dai CF, Chen L 7,8-dihydroxyflavone Ameliorates Motor Deficits Via Suppressing \u03b1\u2010synuclein Expression and Oxidative Stress in the MPTP\u2010induced Mouse Model of Parkinson\u2019s. Wiley Online LibraryXH Li, Dai CF, Chen L, Zhou WT, Han HL et al (2016) ZF DongCNS Neuroscience & Therapeutics, 2016\u2022Wiley Online Library 22:617\u2013624. https:\/\/doi.org\/10.1111\/cns.12555","DOI":"10.1111\/cns.12555"},{"key":"11850_CR100","unstructured":"Jang S, Liu X, Chan C, Liu X, Chan CB, Weinshenker D, Hall RA, Xiao G et al K YeChemistry & biology, 2009\u2022cell.com"},{"key":"11850_CR101","unstructured":"Lin C, Zheng T, Tsou S, Zheng TL, Tsou SH, Chang HM, Tseng LH, Yu CH, Hung CS et al YJ HoBehavioural Brain Research, 2022\u2022Elsevier"},{"key":"11850_CR102","doi-asserted-by":"publisher","unstructured":"Antonini A, Tesei S, Zecchinelli A Randomized study of sertraline and low-dose amitriptyline in patients with Parkinson\u2019s disease and depression: effect on quality of life. Wiley Online LibraryA Antonini, Tesei S, Zecchinelli A, Barone P, Gaspari DD, Canesi M, Sacilotto G et al (2006) N MeucciMovement disorders: official journal of the Movement Disorder Society, 2006\u2022Wiley Online Library 21:1119\u20131122. https:\/\/doi.org\/10.1002\/mds.20895","DOI":"10.1002\/mds.20895"},{"key":"11850_CR103","unstructured":"Neuroprotection in Glaucoma. books.google.comBHM II, DL Stankowska, RR KrishnamoorthyGlaucoma: Basic and Clinical Concepts, 2011\u2022books.google.com"},{"key":"11850_CR104","unstructured":"Nie S, Xu Y, Chen G, Xu Y, Chen G, Ma K, Han C, Guo Z, Zhang Z, Ye K et al X CaoNeuropharmacology, 2015\u2022Elsevier"},{"key":"11850_CR105","doi-asserted-by":"publisher","unstructured":"Tamtaji OR, Reiter RJ, Alipoor R Melatonin and Parkinson disease: current status and future perspectives for molecular mechanisms. SpringerOR Tamtaji, Reiter RJ, Alipoor R, Dadgostar E, Kouchaki E et al (2020) Z AsemiCellular and molecular neurobiology, 2020\u2022Springer 40:15\u201323. https:\/\/doi.org\/10.1007\/s10571-019-00720-5","DOI":"10.1007\/s10571-019-00720-5"},{"key":"11850_CR106","unstructured":"Yoo J, Lee B, Sok D, Lee BD, Sok DE, Ma JY et al MR KimRedox biology, 2017\u2022Elsevier"},{"key":"11850_CR107","unstructured":"Ferlazzo N, Andolina G, Cannata A, Andolina G, Cannata A, Costanzo MG, Rizzo V, Curr\u00f2 M, Ientile R et al D CaccamoAntioxidants, 2020\u2022mdpi.com"},{"key":"11850_CR108","doi-asserted-by":"publisher","unstructured":"Zhao X, Kong D, Zhou Q et al (2021) Baicalein alleviates depression-like behavior in rotenone- induced Parkinson\u2019s disease model in mice through activating the BDNF\/TrkB\/CREB pathway. Biomed Pharmacotherapy 140. https:\/\/doi.org\/10.1016\/j.biopha.2021.111556","DOI":"10.1016\/j.biopha.2021.111556"},{"key":"11850_CR109","doi-asserted-by":"publisher","unstructured":"Singh R, Zahra W, Sen Singh S et al (123AD) Oleuropein confers neuroprotection against rotenone-induced model of Parkinson\u2019s disease via BDNF\/CREB\/Akt pathway. nature.comR Singh, W Zahra, SS Singh, H Birla, AS Rathore, PK Keshri, H Dilnashin, S SinghScientific reports, 2023\u2022nature.com. https:\/\/doi.org\/10.1038\/s41598-023-29287-4","DOI":"10.1038\/s41598-023-29287-4"},{"key":"11850_CR110","doi-asserted-by":"crossref","unstructured":"Jin T, Zhang Y, Botchway B, et al Curcumin can improve Parkinson\u2019s disease via activating BDNF\/PI3k\/Akt signaling pathways. ElsevierT Jin, Y Zhang, BOA Botchway, J Zhang, R Fan, Y Zhang, X LiuFood and Chemical Toxicology, 2022\u2022Elsevier","DOI":"10.1016\/j.fct.2022.113091"},{"key":"11850_CR111","doi-asserted-by":"crossref","unstructured":"Mohamed Y, Salama A, \u2026 MR-I, 2023 undefined Neuroprotective effect of secukinumab against rotenone induced Parkinson\u2019s disease in rat model: Involvement of IL-17, HMGB-1\/TLR4 axis and BDNF\/TrKB cascade. ElsevierYT Mohamed, A Salama, MA Rabie, MA Abd El FattahInternational Immunopharmacology, 2023\u2022Elsevier","DOI":"10.1016\/j.intimp.2022.109571"},{"key":"11850_CR112","doi-asserted-by":"publisher","unstructured":"Kang SS, Wu Z, Liu X Treating Parkinson\u2019s disease via activation of BDNF\/TrkB signaling pathways and inhibition of delta-secretase. SpringerSS Kang, Wu Z, Liu X, Edgington-Mitchell L, YeNeurotherapeutics K et al (2022) 2022\u2022Springer 19:1283\u20131297. https:\/\/doi.org\/10.1007\/s13311-022-01248-1","DOI":"10.1007\/s13311-022-01248-1"},{"key":"11850_CR113","doi-asserted-by":"publisher","first-page":"111338","DOI":"10.1016\/j.brainresbull.2025.111338","volume":"226","author":"H Alnoaman","year":"2025","unstructured":"Alnoaman H, Al-Kuraishy HM, Al-Gareeb AI et al (2025) Dysregulation of proBDNF\/p75NTR and BDNF\/TrkB Signaling in Acute Ischemic Stroke: Different Sides of the Same Coins. Brain Res Bull 226:111338. https:\/\/doi.org\/10.1016\/j.brainresbull.2025.111338","journal-title":"Brain Res Bull"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11850-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11850-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11850-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T13:16:22Z","timestamp":1777295782000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11850-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":113,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11850"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11850-7","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"24 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing financial interests or commercial relationships that could constitute a potential conflict of interest in the conduct of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"675"}}